Journal
DRUG DESIGN DEVELOPMENT AND THERAPY
Volume 16, Issue -, Pages 183-190Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S325852
Keywords
hedgehog pathway inhibitors; surgery; radiotherapy; immunotherapy; skin cancer
Categories
Ask authors/readers for more resources
Basal cell carcinoma is the most common cancer in Caucasians and requires a multi-modal approach for treatment.
Basal cell carcinoma (BCC) is the most common cancer in Caucasians, and its incidence continues to rise. Generally, BCCs have good outcomes when diagnosed and treated early. However, 1-10% of patients will develop advanced disease due to either delays in accessing treatment or aggressive tumors that may be refractory to treatment. Locally advanced basal cell carcinomas (laBCCs) are large, aggressive, or recurrent tumors that have the potential to invade surrounding tissues including bone, cartilage, nerve, and muscle. Treatment requires a multi-disciplinary approach where different modalities including surgery, radiation therapy, Hedgehog Pathway Inhibitors, and immunotherapy can be considered.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available